Technical Analysis for XXII - 22nd Century Group, Inc.

Grade Last Price % Change Price Change
grade F 0.97 -1.24% -0.01
XXII closed down 1.24 percent on Thursday, February 20, 2020, on 70 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical XXII trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -1.24%
Fell Below 50 DMA Bearish -1.24%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.83%
Calm After Storm Range Contraction -5.83%
Narrow Range Bar Range Contraction -5.83%
Inside Day Range Contraction -5.83%
20 DMA Support Bullish -13.39%
50 DMA Support Bullish -13.39%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It develops smoking cessation products for smokers who are unable or unwilling to quit smoking; and modified risk tobacco products that reduce exposure to certain tobacco smoke toxins compared to conventional cigarettes. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than tobacco in cigarettes; and BRAND B cigarettes' with smoke that contains the lowest amount of tar per milligram of nicotine. 22nd Century Group, Inc. was founded in 1998 and is based in Clarence, New York.
Biotechnology Genetic Engineering Psychoactive Drugs Tobacco Cigarette Smoking Cessation Nicotine Nicotinic Agonists Smoking Tobacco Smoking

Is XXII a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.56
52 Week Low 0.7004
Average Volume 2,533,145
200-Day Moving Average 1.67
50-Day Moving Average 1.02
20-Day Moving Average 1.00
10-Day Moving Average 1.01
Average True Range 0.10
ADX 17.31
+DI 19.01
-DI 30.11
Chandelier Exit (Long, 3 ATRs ) 0.91
Chandelier Exit (Short, 3 ATRs ) 1.13
Upper Bollinger Band 1.13
Lower Bollinger Band 0.88
Percent B (%b) 0.37
BandWidth 25.18
MACD Line -0.01
MACD Signal Line -0.02
MACD Histogram 0.0056
Fundamentals Value
Market Cap 99.68 Million
Num Shares 103 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -6.93
Price-to-Sales 20.78
Price-to-Book 9.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.05
Resistance 3 (R3) 1.04 1.01 1.03
Resistance 2 (R2) 1.01 0.99 1.01 1.03
Resistance 1 (R1) 0.99 0.98 0.98 1.00 1.02
Pivot Point 0.96 0.96 0.95 0.96 0.96
Support 1 (S1) 0.94 0.94 0.93 0.95 0.92
Support 2 (S2) 0.91 0.93 0.91 0.91
Support 3 (S3) 0.89 0.91 0.91
Support 4 (S4) 0.90